Table 1.
CD19 CAR clinical trials presented at the 55th ASH annual meeting in 2013*
NHL indicates non-Hodgkin lymphoma; allo-HSCT, allogeneic hematopoietic stem cell transplantation; aAPC, artificial APC; PR, partial response; and SD, stable disease.
*
All abstracts can be found in Blood (ASH Annual Meeting Abstracts), 2013, volume 122, issue 21.
